Visual Outcomes after Proton Therapy for Recurrent Uveal Melanoma
Ophthalmology Retina · 2024
DOI: 10.1016/j.oret.2024.06.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmology Retina, 2024. Verfasst von Megan S Steinkerchner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Uveal Neoplasms, Melanoma, Proton Therapy, Visual Acuity. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.
- Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts. Electronic address: ivana_kim@meei.harvard.edu.
Zitieren
APA
Steinkerchner, M. S., Hartley, C. D., Lane, A. M., Wu, F., Gragoudas, E. S., & Kim, I. K. (2024). Visual Outcomes after Proton Therapy for Recurrent Uveal Melanoma. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2024.06.004
Vancouver
Steinkerchner MS, Hartley CD, Lane AM, Wu F, Gragoudas ES, Kim IK. Visual Outcomes after Proton Therapy for Recurrent Uveal Melanoma. Ophthalmology Retina. 2024. doi:10.1016/j.oret.2024.06.004
BibTeX
@article{Steinkerchner2024,
author = {Steinkerchner, Megan S and Hartley, Caleb D and Lane, Anne M and Wu, Frances and Gragoudas, Evangelos S and Kim, Ivana K},
title = {Visual Outcomes after Proton Therapy for Recurrent Uveal Melanoma},
journal = {Ophthalmology Retina},
year = {2024},
doi = {10.1016/j.oret.2024.06.004}
}
EUVIMED